STAT News · Scour

A new trick for old science, and biotech VCs’ scrambled playbook

statnews.com·5w

STAT+: A new health care blueprint from a key Democratic think tank

statnews.com·5w

STAT+: 5 years after lupus breakthrough, CAR-T is still surprising autoimmunity researchers

statnews.com·5w

STAT+: FDA rejects an industry proposal to deregulate some AI devices

statnews.com·5w

STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more

statnews.com·5w

STAT+: Genetics may shape GLP-1 outcomes, slightly

statnews.com·5w

C-section rate in 2025 highest in a decade

statnews.com·5w

Opinion: As a palliative care physician, I’m nervous about the Medicare infusion of $100 million for ‘functional or lifestyle medicine’

statnews.com·5w

Opinion: Tastiness is not why people overeat

statnews.com·5w

STAT+: Biotech VCs, used to a winning formula in drug development, face disruption

statnews.com·5w

Opinion: The Pasteur Institute of Iran illustrates important truths about global public health

statnews.com·5w

STAT+: Trump promised to clamp down on health insurers. His policies are enriching them

statnews.com·5w

STAT+: Which U.S. metros have the highest health spending? The answer might surprise you

statnews.com·5w

Team approach to lowering high blood pressure worked even in ‘a tough landscape’

statnews.com·5w

STAT+: Influential Democratic think tank pushes plan for government to lower health care costs

statnews.com·5w

STAT+: Trump administration drops court fight to cap NIH payments for research overhead costs

statnews.com·5w

Smart contact lens monitors eye pressure and delivers glaucoma drugs in early tests

statnews.com·5w

STAT+: Steve Ubl to step down as CEO of PhRMA

statnews.com·5w

STAT+: Terns’ drug may not be as competitive as many initially thought

statnews.com·5w

STAT+: 23andMe finds genetic changes appear to help predict response to GLP-1 drugs for weight loss

statnews.com·5w

Log in to enable infinite scrolling